Deutsche Bank Initiates CONMED With Buy
Analysts at Deutsche Bank initiated coverage on CONMED Corporation (NASDAQ: CNMD) with a Buy rating.
The target price for CONMED is set to $63.
CONMED shares have gained 7.29 percent over the past 52 weeks, while the S&P 500 index has surged 11.87 percent in the same period.
CONMED shares closed at $50.16 on Friday.
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.